Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04906876
Title 9-ING-41Combined With Chemotherapy in Adolescents and Adults
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors Brown University
Indications

malignant fibrous histiocytoma

osteosarcoma

myxofibrosarcoma

liposarcoma

Ewing sarcoma

angiosarcoma

sarcoma

spindle cell sarcoma

synovial sarcoma

leiomyosarcoma

rhabdomyosarcoma

Therapies

9-ING-41 + Docetaxel + Gemcitabine

Age Groups: senior | child | adult
Covered Countries USA


No variant requirements are available.